Mandi Pratt-Chapman, MA, associate center director for patient-centered initiatives and health equity at GW Cancer Center, accepted a check from the Avon Foundation at the annual Avon Walk in Washington, D.C. The money will fund a patient navigator who will provide resources to help breast cancer patients in the D.C. area.
A team of researchers at GW Cancer Center found that T-cells lacking in the HDAC11 enzyme performed better in attacking cancer tumor cells. This research highlights the importance of treating HDAC11 as an immunotherapeutic target.
Norman Lee, PhD, professor of pharmacology and physiology, published research in Nature Communications finding that a form of genetic variation, called differential RNA splicing, may have a role in tumor aggressiveness and drug resistance in African American men with prostate cancer.
Jesse Pines, MD, senior author and director of the Center for Healthcare Innovation and Policy ResearchJesse Pines, MD, senior author and director of the Center for Healthcare Innovation and Policy Research
The GW Cancer Center is pleased to announce the opening of the Supportive Oncodermatology Clinic. This clinic is the only one of its kind in the Washington, D.C. region, and one of only a handful of such clinics in the country.
Eduardo Sotomayor, MD, director of the GW Cancer Center, published research looking at the development of resistance to Ibrutinib, a drug used to treat patients suffering with mantle cell lymphoma.
David Diemert, MD, associate professor, and Jeffrey Bethony, PHD, professor, both in the Department of Microbiology, Immunology, and Tropical Medicine, received a $3 million UOI grant from the National Institutes of Health to test the efficacy of a candidate recombinant hookworm vaccine.
Raya Elfadel Kheirbek, MD, MPH, associate professor of medicine at the GW School of Medicine and Health Sciences published research in the Journal of the American Geriatrics Society, about the long health and life spans of centenarian veterans.